Treatment of opioid dependence with depot buprenorphine (CAM2038) in custodial settings

Abstract

This first study of depot buprenorphine in custodial settings showed treatment retention and outcomes comparable to those observed in community settings and for other opioid agonist treatment used in custodial settings, without increased risk of diversion.